| RS2112431809 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112437401 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112437820 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112438432 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112440626 |
OXCT1
|
Health Risk |
Likely pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS2112442370 |
CWC27
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome, Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome |
| RS2112443938 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2112443985 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2112444143 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2112449032 |
VCAN
|
Health Risk |
Pathogenic |
— |
| RS2112453728 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112456363 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112457150 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112457520 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2112457636 |
LIFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2112459497 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2112460011 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112462051 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2112463671 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112463755 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS2112467862 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112468012 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112469361 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112470883 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2112471375 |
OXCT1
|
Health Risk |
Likely pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS2112474795 |
RASA1
|
Health Risk |
Pathogenic |
Capillary infantile hemangioma, Capillary infantile hemangioma |
| RS2112474880 |
RASA1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2112477601 |
GHR
|
Health Risk |
Likely pathogenic |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS2112483439 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112484806 |
RASA1
|
Health Risk |
Pathogenic |
— |
| RS2112484882 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112485022 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Cardiovascular phenotype |
| RS2112485870 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2112486988 |
RASA1
|
Health Risk |
Pathogenic |
Angioosteohypertrophic syndrome, Angioosteohypertrophic syndrome |
| RS2112486996 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112487030 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2112490719 |
RASA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112490726 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112491212 |
ERCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
ERCC8-related disorder, Cockayne syndrome |
| RS2112491551 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2112491568 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2112492062 |
CCNH;RASA1
|
Health Risk |
Pathogenic |
— |
| RS2112492304 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112492912 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2112495236 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2112495246 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2112495582 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112495617 |
RASA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation 1 |
| RS2112495772 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112498297 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2112499273 |
VCAN
|
Health Risk |
Pathogenic |
— |
| RS2112500780 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112500793 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2112509032 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation 1 |
| RS2112513256 |
CCNH;RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2112516716 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2112517213 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation 1 |
| RS2112517308 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112518616 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2112522829 |
ERCC8
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Cockayne syndrome type 1 |
| RS2112522943 |
ERCC8
|
Health Risk |
Pathogenic |
UV-sensitive syndrome 2, Cockayne syndrome type 1 |
| RS2112525375 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112529559 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112530008 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112530498 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112532297 |
ERCC8
|
Health Risk |
Pathogenic |
— |
| RS2112532350 |
ERCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2112564371 |
LIFR
|
Health Risk |
Likely pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2112564806 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2112564811 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2112580593 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112582627 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112583121 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112583680 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112617391 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112768333 |
ALDH7A1
|
Health Risk |
Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS2112768468 |
ALDH7A1
|
Health Risk |
Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS2112794702 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS2112797412 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Endometrial carcinoma, Hereditary cancer-predisposing syndrome |
| RS2112797490 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112797887 |
MSH3
|
Health Risk |
Likely pathogenic |
Endometrial carcinoma, Endometrial carcinoma |
| RS2112798504 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS2112798603 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112798778 |
MSH3
|
Health Risk |
Likely pathogenic |
— |
| RS2112801785 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112801912 |
MSH3
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS2112802656 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS2112802725 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, See cases |
| RS2112804344 |
ALDH7A1
|
Health Risk |
Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS2112804365 |
ALDH7A1
|
Health Risk |
Pathogenic |
— |
| RS2112806309 |
SMN1
|
Health Risk |
Pathogenic |
Spinal muscular atrophy, Spinal muscular atrophy |
| RS2112806512 |
SMN1
|
Health Risk |
Pathogenic |
Spinal muscular atrophy, Werdnig-Hoffmann disease |
| RS2112808726 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112808731 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112808747 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Endometrial carcinoma |
| RS2112808805 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112808820 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112808839 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112808889 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112808916 |
MSH3
|
Health Risk |
Pathogenic |
— |